Primary liver cancer: worldwide incidence and trends.

By F. Bosch, J. Ribes, Mireia Díaz, R. Clèries. Gastroenterology, 2004

2,563 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/2904ea57a9ccc36896fd4b9eb8e8eccf5bc90046

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Hepatology

Citations in the corpus

ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. (2021, neutral): “Reportingofadverse eventsbyconsumersandhealthcareprovidersisvoluntary,through theMEDWATCHsystem(97).”
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma (2007, methodology): “... phase and washout in 1 of the venous phases (portal or delayed), (2) suggestive of HCC, but nonconclusive: nodules showing enhancement during the hepatic arterial phase without washout; even if pseudocapsule of fatty content were demonstrated, lesions were still included in this category; (3) dy”
Resection and Liver Transplantation for Hepatocellular Carcinoma (2005, background): “Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide,1 and its incidence will increase further in the next two decades in both Europe and the United States.2,3 This is a result of the spread of hepatitis C virus (HCV) and hepatitis B virus (HBV) infection during the past century.”
miR-221 overexpression contributes to liver tumorigenesis (2009, background): “H carcinoma (HCC) is one of the most common malignant tumors in the world (1).”
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015, result): “Similarly, the predominant risk factors identified in the BRIDGE study are consistent with those previously reported (25, 27), comprising HBV infection in Asian countries (excluding Japan) and HCV infection in Europe, North America and Japan.”
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2018, background): “In high-risk countries with major HBV prevalence, the mean age at diagnosis is usually below 60 years; however, it is not infrequent to observe HCC from childhood to early adulthood, underlying the impact of viral exposures early in life.(7) In intermediate- or low-incidence areas, most cases appear”
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. (2014, background): “Although there will be only an estimated 33,000 new cases of liver and intrahepatic bile duct cancer in the United States in 2014 (1), hepatocellular carcinoma (the most common type of liver cancer) is the most frequent solid tumor worldwide and the third leading cause of global cancer-related death”